• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Sci Rep . Prevalence and prognostic value of neurological affections in hospitalized patients with moderate to severe COVID-19 based on objective as

tetano

Editor, Senior Moderator
Sci Rep


. 2023 Nov 10;13(1):19619.
doi: 10.1038/s41598-023-46124-w. Prevalence and prognostic value of neurological affections in hospitalized patients with moderate to severe COVID-19 based on objective assessments

Carolin Balloff[SUP] 1 2 [/SUP], Carolina Bandlow[SUP] 1 [/SUP], Michael Bernhard[SUP] 3 [/SUP], Timo Brandenburger[SUP] 4 [/SUP], Patricia Bludau[SUP] 1 [/SUP], Saskia Elben[SUP] 1 [/SUP], Torsten Feldt[SUP] 5 [/SUP], Christian J Hartmann[SUP] 1 6 [/SUP], Elisa Heinen[SUP] 1 [/SUP], Jens Ingwersen[SUP] 1 [/SUP], Corinna Jansen[SUP] 1 [/SUP], Björn-Erik O Jensen[SUP] 5 [/SUP], Detlef Kindgen-Milles[SUP] 4 [/SUP], Tom Luedde[SUP] 5 [/SUP], Iris-Katharina Penner[SUP] 1 7 [/SUP], Isabel Slink[SUP] 1 [/SUP], Kim Stramm[SUP] 1 [/SUP], Ann-Kathrin Telke[SUP] 1 [/SUP], Jörg Timm[SUP] 8 [/SUP], Lana Vetterkind[SUP] 1 [/SUP], Christian Vollmer[SUP] 4 [/SUP], Georg Wolff[SUP] 9 [/SUP], Alfons Schnitzler[SUP] 1 6 [/SUP], Sven G Meuth[SUP] 1 [/SUP], Stefan J Groiss[SUP] #[/SUP][SUP] 1 6 10 [/SUP], Philipp Albrecht[SUP] #[/SUP][SUP] 11 12 [/SUP]



Affiliations
Abstract

Neurological manifestations of coronavirus disease 2019 (COVID-19) have been frequently described. In this prospective study of hospitalized COVID-19 patients without a history of neurological conditions, we aimed to analyze their prevalence and prognostic value based on established, standardized and objective methods. Patients were investigated using a multimodal electrophysiological approach, accompanied by neuropsychological and neurological examinations. Prevalence rates of central (CNS) and peripheral (PNS) nervous system affections were calculated and the relationship between neurological affections and mortality was analyzed using Firth logistic regression models. 184 patients without a history of neurological diseases could be enrolled. High rates of PNS affections were observed (66% of 138 patients receiving electrophysiological PNS examination). CNS affections were less common but still highly prevalent (33% of 139 examined patients). 63% of patients who underwent neuropsychological testing (n = 155) presented cognitive impairment. Logistic regression models revealed pathology in somatosensory evoked potentials as an independent risk factor of mortality (Odds Ratio: 6.10 [1.01-65.13], p = 0.049). We conclude that hospitalized patients with moderate to severe COVID-19 display high rates of PNS and CNS affection, which can be objectively assessed by electrophysiological examination. Electrophysiological assessment may have a prognostic value and could thus be helpful to identify patients at risk for deterioration.


 
Back
Top Bottom